Mark Battle

858 total citations
27 papers, 477 citations indexed

About

Mark Battle is a scholar working on Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Battle has authored 27 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Psychiatry and Mental health and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Battle's work include Medical Imaging Techniques and Applications (10 papers), Dementia and Cognitive Impairment Research (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Mark Battle is often cited by papers focused on Medical Imaging Techniques and Applications (10 papers), Dementia and Cognitive Impairment Research (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Mark Battle collaborates with scholars based in Spain, United Kingdom and Sweden. Mark Battle's co-authors include Julian Goggi, Christopher Buckley, Matthew Morrison, Lucy Allen, Gill Farrar, Val J. Lowe, Ariane Bollack, Christopher C. Rowe, Juan Domingo Gispert and David Vállez García and has published in prestigious journals such as Neurology, Cancer Research and Journal of Nuclear Medicine.

In The Last Decade

Mark Battle

27 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Battle Spain 11 225 144 129 89 61 27 477
Isabelle Stangier Germany 7 290 1.3× 136 0.9× 141 1.1× 66 0.7× 77 1.3× 8 496
S. Askienazy France 15 203 0.9× 69 0.5× 38 0.3× 57 0.6× 10 0.2× 46 584
Yasuhiko Ikari Japan 12 350 1.6× 136 0.9× 128 1.0× 42 0.5× 4 0.1× 21 573
Makoto Ueno Japan 10 46 0.2× 21 0.1× 60 0.5× 66 0.7× 26 0.4× 28 443
In Kook Chun South Korea 10 224 1.0× 76 0.5× 114 0.9× 51 0.6× 13 0.2× 20 529
Mitsuhiro Matsuo Japan 13 55 0.2× 143 1.0× 30 0.2× 282 3.2× 36 0.6× 39 764
Georges Weissgerber Switzerland 12 383 1.7× 29 0.2× 17 0.1× 265 3.0× 18 0.3× 21 884
Eline E. Verwer Netherlands 13 252 1.1× 101 0.7× 175 1.4× 57 0.6× 2 0.0× 17 501
Barbara E. Glick‐Wilson United States 12 141 0.6× 21 0.1× 25 0.2× 145 1.6× 16 0.3× 21 392

Countries citing papers authored by Mark Battle

Since Specialization
Citations

This map shows the geographic impact of Mark Battle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Battle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Battle more than expected).

Fields of papers citing papers by Mark Battle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Battle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Battle. The network helps show where Mark Battle may publish in the future.

Co-authorship network of co-authors of Mark Battle

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Battle. A scholar is included among the top collaborators of Mark Battle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Battle. Mark Battle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bollack, Ariane, Lyduine E. Collij, Mahnaz Shekari, et al.. (2024). The Centiloid scale: guidance on clinical context of use from the AMYPAD Consortium. Alzheimer s & Dementia. 20(S2). 1 indexed citations
2.
Collij, Lyduine E., Ariane Bollack, Renaud La Joie, et al.. (2024). Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium. Alzheimer s & Dementia. 20(12). 9037–9048. 22 indexed citations
3.
Collij, Lyduine E., Giovanni B. Frisoni, Frederik Barkhof, et al.. (2023). Inverse relationship between education and amyloid burden in individuals with subjective cognitive decline plus and mild cognitive impairment. Alzheimer s & Dementia. 19(S3). 1 indexed citations
4.
Pemberton, Hugh, Christopher Buckley, Mark Battle, et al.. (2023). Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment. EJNMMI Research. 13(1). 48–48. 5 indexed citations
5.
Pemberton, Hugh, Lyduine E. Collij, Fiona Heeman, et al.. (2022). Quantification of amyloid PET for future clinical use: a state-of-the-art review. European Journal of Nuclear Medicine and Molecular Imaging. 49(10). 3508–3528. 104 indexed citations
6.
Shekari, Mahnaz, Gemma Salvadó, Mark Battle, et al.. (2021). Evaluating robustness of the Centiloid scale against variations in amyloid PET image resolution. Alzheimer s & Dementia. 17(S1). 3 indexed citations
7.
Battle, Mark, Val J. Lowe, David S. Knopman, et al.. (2018). Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods. EJNMMI Research. 8(1). 107–107. 70 indexed citations
8.
Battle, Mark, Michel Eisenblaetter, Graeme McRobbie, et al.. (2015). c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer. Journal of Nuclear Medicine. 57(5). 765–770. 26 indexed citations
9.
Rodnick, Melissa E., Brian G. Hockley, Phillip Sherman, et al.. (2013). Novel Fluorine-18 PET Radiotracers Based on Flumazenil for GABA(A) Imaging in the Brain. PubMed Central. 12 indexed citations
10.
Jackson, Alexander, Mark Battle, Dennis M. O’Shea, et al.. (2013). Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor. Nuclear Medicine and Biology. 41(2). 196–202. 7 indexed citations
11.
Jackson, Alexander, Julian Goggi, Mark Battle, et al.. (2012). The development of potential new fluorine-18 labelled radiotracers for imaging the GABAA receptor. Bioorganic & Medicinal Chemistry Letters. 23(3). 821–826. 14 indexed citations
12.
Evans, Paul M., et al.. (2012). Abstract 357: Nonclinical tumor efficacy studies of [18F]AH113804, a novel PET imaging agent with high affinity for the human c-Met receptor. Cancer Research. 72(8_Supplement). 357–357. 2 indexed citations
13.
Battle, Mark, et al.. (2011). Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αVβ3-Integrin and αVβ5-Integrin Imaging Agent. Journal of Nuclear Medicine. 52(3). 424–430. 96 indexed citations
14.
Gaeta, Alessandra, Julian Goggi, Paul A. Jones, et al.. (2010). Use of 2-[18F]fluoroethylazide for the Staudinger ligation – Preparation and characterisation of GABAA receptor binding 4-quinolones. Bioorganic & Medicinal Chemistry Letters. 20(15). 4649–4652. 23 indexed citations
15.
Edwards, David S., et al.. (2008). 99mTc-NC100692 — a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation. Nuclear Medicine and Biology. 35(3). 365–375. 26 indexed citations
16.
Edwards, David S., et al.. (2007). The biodistribution of NC100668 and the effect of excess NC100668 on the biodistribution and kidney retention of 99mTc-NC100668 in the rat. Nuclear Medicine and Biology. 34(3). 315–323. 3 indexed citations
17.
18.
Edwards, David S., et al.. (2006). 99mTc-NC100668, a new tracer for imaging venous thromboemboli: pre-clinical biodistribution and incorporation into plasma clots in vivo and in vitro. European Journal of Nuclear Medicine and Molecular Imaging. 33(11). 1258–1265. 10 indexed citations
19.
20.
Calvo, Ran, Josep‐María Ribera, Mark Battle, et al.. (1997). Acute Promyelocytic Leukemia in a HIV Seropositive Patient. Leukemia & lymphoma. 26(5-6). 621–624. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Stangier Breakdown of academic impact, for papers by S. Askienazy Breakdown of academic impact, for papers by Yasuhiko Ikari Breakdown of academic impact, for papers by Makoto Ueno Breakdown of academic impact, for papers by In Kook Chun Breakdown of academic impact, for papers by Mitsuhiro Matsuo Breakdown of academic impact, for papers by Georges Weissgerber Breakdown of academic impact, for papers by Eline E. Verwer Breakdown of academic impact, for papers by Barbara E. Glick‐Wilson
Rankless by CCL
2026